Based on ACR rules, allopurinol is strongly encouraged as a first-line urate-decreasing medication. Genetic testing is usually recommended (for the variant identified as HLA B*5801) before beginning allopurinol as the carriers of the gene are at an elevated hazard of a extreme allergic response.Penyelidikan lanjutan sangat berkemungkinan memberi im… Read More